InterMune Inc (NASDAQ:ITMN) Investor Alert: Investigation of Takeover by Roche
August 27, 2014 at 08:30 AM EDT
San Diego, CA -- (SBWIRE) -- 08/27/2014 -- An investigation on behalf of investors, who currently hold shares of InterMune Inc (NASDAQ:ITMN), was announced concerning whether the takeover of InterMune Inc by Roche at $74.00 per share is unfair to NASDAQ:ITMN stockholders.